السلطة الوطنية الفلسطينية

وزارة الصحة

الإدارة العامة للصيدلة
دائرة التسجيل الدوائي / /

Palestinian National Authority

Ministry Of HealthGeneralAdministration of Pharmacy
Drug Registration Department

Pre-approval Applicationfor Registration of Veterinary Medicinal Product

To: The Director of Registration Department

I hereby request your approval to register the following veterinary medicinal product:-

  1. Applicant:
  2. Name of the applicant (responsible pharmacist/vet.): ………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………
  • Address: ………………………………………………………………………………………………………………………………………………………………………………………………………………………………………….……………………………………
  1. Veterinary Medicinal product:

Name of Suggested product: …………………………………………………….

Dosage form: …………………………………………………………

Packaging: ……………………………………………………………

Strength: ………………………………………………………………

  1. Manufacturer:

Name: ……………………………………………………………………..

Address: …………………………………………………………………..

Address of the branch supplying Palestine (for imported drugs only): ……………………………………………………………………………………………………………………………………………………………………………………

  1. Purpose of registration:

( ) Manufacturing and marketing ( ) Importing and marketing

( ) Packing and marketing

( ) Veterinary use

  1. Suggested indications of the drug:

……………………………………………………………………………………………………………………………………………………………………………………

  1. Similar international brand name(s) containing the same active ingredient/s and their manufacturers: ………………………………………………………………………………………………………………………………………………………………………………………..……………………………………………………………………………
  1. Price:

Suggested price to consumer: ………………………………………………..

Export price to Palestine ( F.O.B/ C&F):…………………………………….

Price to the public in the country of origin: ………………………………….

Signature of the Responsible Pharmacist Date

…………………… ……………………

************************************************************************

For the office use only

Date of receiving the application: ………………………….………………….

Name of person receiving the application: ……………………………..……………….

Decision:

( ) Approved

( ) Rejected for: ………………………………………………………………………………………………………………………………………………..

( ) Others: …………………………………………………………………………………………………………………………………………………………………………………………………………………….

Head of the Reg. Section Date:

……………………….

Head of the Reg. Division Date:

……………………….

Director of Registration Dept.Date:

………………………..

Application Form for Veterinary Medicinal Product Registration

To: The Director of Drug Registration Department

1. Particulars of applicant:

Name of the Applicant: ......

Address: ……………………………………………………………………………….

Telephone No...... Telefax No......

Email:...... Website......

2. Particulars of the manufacturer(s) and activity:

Name:Physical address of Activity

Production site

1......

2......

3......

(Attach copies of GMP certificate from the country of origin drug regulatory Authority Local (DRA) for each site)

3. Particulars of the product:

Name of the product: ......

Dosage form: …………………………….………………………………..………….

Strength: …………………………….………………………………………….…….

Description of the product (colour, shape, size, etc): ……….…………………….……………………………………………………………………………………………………………………….……………………………….

Commercial presentation (packaging and pack sizes applied for in which stability studies were conducted): ……….…………………….…………………………………………………….…….

Route of administration:………………………………………………………………..

Distribution category requested (POM/OTC):…………………………………….....

Proposed shelf life in months:………………………………………………………….

Storage conditions:……………………………………………………………………..

4. Purpose of registration:

( ) Manufacturing & Marketing ( ) Importing & Marketing ( ) Packaging & Marketing

( ) Veterinary use .

5. Price :

Suggested price to the consumer: ......

Export price to Palestine (F.O.B/C&F): ......

Price to the public in the country of origin: ......

6. Composition:

6.1 Active constituents

Name and quantities: ......

6.2 Other constituents (Name only):

......

(Note : For empty shell capsules indicate the type and colour No.)

6.3 Overage:

……………………………………………………………………………………………………………………………………………………………………………………

(Note: If an overage is included it should be stated in what percentage and for what reason).

6.4 Source of active ingredients:

Name: ......

Address: ......

7. Indicate type and percentage of:

7.1 Colouring matter:

......

7.2 Preservative:

......

8. Quality control:

Raw material (active) specifications including manufacturing processes and analytical control procedures carried out as release requirements (to be attached):

......

In-process controls performed (to be attached):

......

Final product specifications and analytical control procedures carried aout as release requirements (to be attached):

......

9. Specifications of packaging material:

Primary container(s):

......

Secondary container(s):

......

10. Stability and shelf life:

10.1 Type of study conducted:

( ) Accelerated ( ) Shelf life( ) Long Term

10.2 Anticipated shelf life of the product according to the stability study:

......

10.3 Change in the physical characteristics anticipated during storage:

......

10.4 Chemical changes anticipated during storage:

......

11. Label and insert information:

11.1 Directions for use:

......

11.2 Contraindication and side effects:

......

11.3 Warning: ......

11.4 Storage conditions:

......

11.5 Withdrawal periods: ......

11.6 Details of drug residues in species intended for human consumption:

......

12. Clinical use:

12.1 Pharmacological action and recommended clinical use :

......

12.2 Proposed route(s) of administration:

......

12.3 Recommended dosage:

......

13. Mechanism of Action: -

......

......

......

......

......

......

......

......

......

......

14. Toxicology (Pathology, toxicology, teratology): -

......

......

......

......

......

......

......

......

......

15. Current registration status: -

State the names of all countries (including the country of manufacture) where the product is registered (for imported products):

......

16. Certificate of a pharmaceutical product (WHO type) (for imported products): -

......

17. Supporting materials: -

17.1 Samples:

  • Provide a minimum quantity of the product in commercial pack sufficient to conduct three sets of full analysis.
  • Provide a minimum of 200mg of reference standards working standard with the corresponding certificate of analysis.

17.2 Product information:

  • Provide copies of package inserts, labels and samples of packaging materials.
  • Provide samples of the proposed advertising and promotional materials if any.

18. Declaration: -

I, the undersigned hereby apply for registration of the product detailed above and declare that all the information contained herein and in the annextures is correct and true.

I enclose a fee of US $: …………………………………. Receipt.

No………………………………………………………...

Date:……………………………………………………...

Signed:……………………………………………………

Full name of signatory:……………………………………………….

Official designation and qualification:………………………………..

…………………… ……………………

************************************************************************

For the office use only

Date of receiving the application: ………………………….………………….

Name of person receiving the application: ……………………………..……………….

Decision:

( ) Approved

( ) Rejected for: ………………………………………………………………………………………………………………………………………………..

( ) Others: …………………………………………………………………………………………………………………………………………………………………………………………………………………….

Head of the Reg. Section Date:

……………………….

Head of the Reg. Division Date:

……………………….

Director of Registration Dept.Date:

………………………..

Registration Renewal Application Form

To: The Director of Drug Registration Department

We hereby request that the registration of the following veterinary medicinal product to be renewed.

-Applicant information:

  • Applicant's Name (Responsible pharmacist or responsible vet)……………………
  • Manufacturer name and address:……………………………………………….…..
  • Name and address of the importer (for imported drugs only): ………………….…

-Product information:

  • Registration No:…………………
  • Name of the medicinal product: ……………………………………….
  • Dosage form and strength: …………………………………………..
  • Quantity per pack: ………………………………………………..
  • Purpose of re-registration:
  • ( ) Manufacturing and marketing.
  • ( ) Import and marketing.
  • Any previousely approved restrictions on the marketing of the product: ……………………………………………………………………………………………………………………………………………

Signature of the responsible pharmacist/Vet. Date

………………………… ………………

************************************************************

Attachments:

□ Original receipt confirming payment of re-registration fees.

□ Latest master formula.

□ Latest method(s) of analysis for the finished.

□ The shelf-life stability study.

□ The latest packaging materials specifications (primary and secondary) attached with sample from secondary packaging materials or coloured artwork.

□Valid certificate of pharmaceutical product (CPP) (Imported drugs).

□ Sufficient samples from finished products and reference materials for analysis purposes.

************************************************************************

For Office use only:

  • Name of receiver:………………………………..
  • Date receiving:……………………………………
  • Remarks:………………………………………………………………………

Signature: …………… Date:………………………

Amendments Application Form

To: The Director of Drug Registration Department

We hereby request the approval of the changes/variations on the registered veterinary product mentioned bellow

Details of the current registration:

  • Name of the veterinary medicinal medicinal product:……………………………….…………......
  • Registration number: …………………………………………………………..…..
  • Dosage form:………………………………..…………………………………..….
  • Composition and strength:……………………………………………………...….
  • Manufacturer address: …………………………………….…….…………..…..…
  • Manufacturing site and address (if different from above)………………………..
  • Importing agent and address:…………………………………………...……..…

Details of the requested amendment:

  • Tabulate the requested amendment(s) in away to show the current and new suggested change(s) (use additional pages of necessary).

………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………

  • Reason(s) for the amendment accompanied with relevant supporting data.

………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………

  • Letter of approval of the amendments from the drug regulatory authority in the country of original.

………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………………

Declaration of the applicant:

I hereby declare that:

□ The change(s) will not adversely affect the quality, efficacy and safety of the product.

□ All condition as set for the notification(s) concerned are fulfilled.

□ The required documentation as specified for the notification(s) have been submitted.

Applicant's Name Applicant's Signature Date

………………………. ……………………………………………

************************************************************************

For Office Use Only:

  • Date of receiving of the application:……………………….…………………….
  • Name of the receiver:…………………………………………….………………
  • Amendment decision:

□ The requested amendment(s) is approved.

□ The requested amendment(s) is rejected for the following reasons:

1. …………………………………………………………………………….

2 ………………………………………………...…………………………...

3. …………………………………..……………………………………….

□ Others, the applicant is requested to:

……………………………………………………………………………………………………………………………………………………………………………………………………………………

………………………..…. …………………………

Head of registration division Director of Reg. Dept.

البيرة-رام الله –مقر الوزارة-المجلس التشريعي القديم، 02-2409827-9 Al-Beireh-Ramallah , 02-2409827-9